Phoniatric studies in myasthenia gravis patients [Phoniatrische untersuchungen an patienten mit myasthenia gravis]

被引:0
作者
Tóth L.
Pap U.
Diószeghy P.
Sziklai I.
机构
[1] HNO-Klinik (Direktor: Prof. Dr. I. Sziklai),
[2] Universität Debrecen,undefined
[3] Ungarn,undefined
[4] Neurologie-Klinik (Direktor: Prof. Dr. L. Csiba),undefined
[5] Universität Debrecen,undefined
[6] Ungarn,undefined
关键词
Myasthenia gravis; Phoniatrics; Voice profile;
D O I
10.1007/s001060050479
中图分类号
学科分类号
摘要
The authors have for the first time evaluated the basic parameters of the voice using computed voice analysis in patients with myasthenia gravis (MG). The aim of the study was to introduce an objective method suitable for the assessment of dysphonic symptoms, which predominate in bulbar, oculobulbar and generalized MG. Voice profile studies included the evaluation of the singing voice range, voice dynamics, maximum phonation time, and mean fundamental frequency and intensity, during speech. The characteristic of the stroboscopic picture was also determine. Investigations were carried out before and after the intake of Mestinon, a reversible cholinesterase inhibitor, and healthy subjects were used as a control group. In MG, the voice range and dynamics are badly impaired, maximum phonation time is shortened, the mean fundamental frequency during speech is increased, while the intensity is decreased. Mestinon resulted in an improvement in all these parameters, however, they were still impaired in comparison to the control subjects. Most changes were found to be statistically significant. The authors emphasize the role of the otolaryngologist and objective phoniatric methods in the evaluation of MG and other myasthenia-like neurological diseases. The use of these methods for the assessment of phoniatric symptoms in neurological diseases is highly recommended.
引用
收藏
页码:981 / 985
页数:4
相关论文
共 50 条
  • [41] Neonatal myasthenia gravis
    Belasco, C
    Carbillon, L
    Louaib, D
    Gaudelus, J
    Uzan, M
    ARCHIVES DE PEDIATRIE, 2000, 7 (03): : 263 - 266
  • [42] Management of myasthenia gravis
    Saperstein, DS
    Barohn, RJ
    SEMINARS IN NEUROLOGY, 2004, 24 (01) : 41 - 48
  • [43] Myasthenia gravisMyasthenia gravis
    W. A. Nix
    P. P. Urban
    Notfall & Rettungsmedizin, 2005, 8 (4): : 275 - 280
  • [44] Myasthenia gravis and sleep
    Stepansky, R
    Zeitlhofer, J
    WIENER KLINISCHE WOCHENSCHRIFT, 2001, 113 (7-8) : 285 - 287
  • [45] Thymectomy in myasthenia gravis
    Atance, PL
    Aragoneses, FG
    Mata, NM
    Fontán, EG
    Medina, DL
    Gómez, JMN
    Blanco, JLM
    Palomino, EO
    Gómez, EF
    ARCHIVOS DE BRONCONEUMOLOGIA, 2001, 37 (05): : 235 - 239
  • [46] Thymectomy for myasthenia gravis
    Urschel, JD
    Grewal, RP
    POSTGRADUATE MEDICAL JOURNAL, 1998, 74 (869) : 139 - 144
  • [47] Myasthenia gravis and pregnancy
    Grover, Kavita M.
    Sripathi, Naganand
    MUSCLE & NERVE, 2020, 62 (06) : 664 - 672
  • [48] A portrait of myasthenia gravis?
    Budrys, V
    EUROPEAN NEUROLOGY, 2005, 54 (04) : 240 - 241
  • [49] Thymectomy for myasthenia gravis
    Guth, S
    Nix, HWA
    Mayer, E
    Schmiedt, W
    Kramm, T
    Moersig, W
    Oelert, H
    ZENTRALBLATT FUR CHIRURGIE, 1997, 122 (08): : 655 - 660
  • [50] The epidemiology of myasthenia gravis
    Phillips, LH
    SEMINARS IN NEUROLOGY, 2004, 24 (01) : 17 - 20